Latest News
Feature
CMS looking to evolve QPP to measure outcomes, not processes
Ms. Verma wrapped her thoughts on value and quality in her broader vision for CMS as one of patient empowerment.
News
FDA approves first trastuzumab biosimilar
The Food and Drug Administration has approved trastuzumab-dkst (Ogivri) as a biosimilar to trastuzumab (Herceptin) for the treatment of patients...
From the Journals
Levofloxacin prophylaxis in AML reduces febrile neutropenia admissions
The results support recommendations made by the Infectious Diseases Society of America and the National Comprehensive Cancer Network.
Conference Coverage
SABCS 2017: Top picks from Dr. William J. Gradishar
Anticipated presentations include updates on dose-dense chemotherapy, ovarian suppression, and extended bisphosphonate treatment for early breast...
Conference Coverage
ENCORE 601 study: Entinostat shows promise in NSCLC
Entinostat given in combination with pembrolizumab demonstrated antitumor activity and acceptable safety in patients with NSCLC in the phase 1b/2...
Feature
FDA: Puerto Rico’s medical supply shortage issues continue
Intravenous saline products and amino acids for injection are both in short supply.
Feature
5 big ways the tax bill could affect health policy
One proposed change could disproportionately effect young physicians.
News
Breakthrough cancer gene assay approved, CMS proposes coverage
FDA approves first breakthrough-designated, next-generation sequencing assay that can detect genetic mutations in 324 genes and two genomic...
Conference Coverage
SABCS 2017: Top picks from Dr. Hope S. Rugo
Anticipated presentations include updates on I-SPY2 and the TEXT and SOFT trials, as well as an evaluation of predicting late recurrences using...
Conference Coverage
ASCT or novel therapies in early relapsing follicular lymphoma?
NEW YORK – Should autologous stem cell transplantation or novel therapies be the next step when a patient with follicular lymphoma experiences...
Feature
HealthCare.gov seeing more action this fall
30% more plans selected so far, compared with last year’s open enrollment.